Sky Max Pharmatech Private Limited - Company Profile

It is a healthcare private limited company based in Patna, Bihar, India, established in 2014.
2014 Patna, Bihar, India Active
Last Updated:
Access Report
About Sky Max Pharmatech Private Limited

Sky Max Pharmatech Private Limited, a active private limited company, was established on 29 May 2014 in Patna, Bihar, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100BR2014PTC022367. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Dharmendra Kumar (Director), Arbind Kumar (Director). Past directors included Krishna Murari Hari, Ram Brind Singh, Ajay Kumar Sharma. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2023. It is based at 26, New Etvarapur, Lalu Path, Phulwarisharif, Patna, Bihar, 804453.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100BR2014PTC022367

  • Registration Number

    022367

  • Incorporation Date

    29 May 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Patna

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** 22.99%
  • Profit Growth **** -4.45%
  • Ebitda **** 166.87%
  • Net Worth -0.35%
  • Total Assets -41.60%
Company report

Sky Max Pharmatech Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Sky Max Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sky Max Pharmatech Private Limited?
Current Directors
Name Designation Appointment Date Status
Dharmendra Kumar Director 29 May 2014 Current
Arbind Kumar Director 16 Dec 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Feb 2021 Past
Pramod Abcsdd Director 12 Feb 2021 Past
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sky Max Pharmatech.

Sky Max Pharmatech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 22.99% increase. The company also saw a slight decrease in profitability, with a 4.45% decrease in profit. The company's net worth dipped by a decrease of 0.35%.

Sky Max Pharmatech revenue growth over time
Sky Max Pharmatech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 22.99%
*******
*******
*******
*******
Revenue from Operations
*******
 22.99%
*******
*******
*******
*******
Total Assets
*******
 -41.60%
*******
*******
*******
*******
Profit or Loss
*******
 -4.45%
*******
*******
*******
*******
Net Worth
*******
 -0.35%
*******
*******
*******
*******
EBITDA
*******
 166.87%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sky Max Pharmatech?

Unlock access to Sky Max Pharmatech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sky Max Pharmatech?

Unlock and access historical data on people associated with Sky Max Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sky Max Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sky Max Pharmatech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sky Max Pharmatech
Recent Activity within the Organization
  • Director Appointment

    Arbind Kumar was appointed as a Director was appointed as a Director on 16 Dec 2025 & has been associated with this company since 5 months 7 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Sky Max Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Sky Max Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Patna. was completed.

  • Director Appointment

    Dharmendra Kumar was appointed as a Director was appointed as a Director on 29 May 2014 & has been associated with this company since 11 years 11 months . was recorded as a recent event.

  • Company Incorporation

    Sky Max Pharmatech Private Limited was registered on 29 May 2014 with Roc Patna & aged 11 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sky Max Pharmatech Private Limited?

The CIN of Sky Max Pharmatech Private Limited is U85100BR2014PTC022367.

Where is Sky Max Pharmatech Private Limited headquartered?

Sky Max Pharmatech Private Limited is headquartered at 26, New Etvarapur, Lalu Path, Phulwarisharif, Patna, Bihar, 804453.

When was Sky Max Pharmatech Private Limited incorporated?

Sky Max Pharmatech Private Limited was incorporated on 29 May 2014.

Who are the current directors of Sky Max Pharmatech Private Limited?

The current directors of Sky Max Pharmatech Private Limited are

What is the primary industry of Sky Max Pharmatech Private Limited?

The primary industry of Sky Max Pharmatech Private Limited is Healthcare.

Is Sky Max Pharmatech Private Limited a listed company?

Sky Max Pharmatech Private Limited is unlisted.

What is the capital structure of Sky Max Pharmatech Private Limited?

The authorized capital of Sky Max Pharmatech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Sky Max Pharmatech Private Limited?

The compliance status of Sky Max Pharmatech Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available